{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:19:33Z","timestamp":1783448373229,"version":"3.55.0"},"reference-count":7,"publisher":"Bioscientifica","issue":"6","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":196,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.1530\/etj-25-0337","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T11:44:06Z","timestamp":1766576646000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":0,"title":["Rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-4498","authenticated-orcid":true,"given":"Emmanuel","family":"Martinod","sequence":"first","affiliation":[{"name":"1"},{"name":"2"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Kuczma","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Tr\u00e9sallet","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Ghander","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Buffet","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"2026070714021384400_bib1","article-title":"Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion","volume":"14","author":"Katoh","year":"2025","journal-title":"Eur Thyroid J"},{"key":"2026070714021384400_bib2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jamasurg.2025.1378","article-title":"Tracheobronchial replacement: a systematic review","volume":"160","author":"Martinod","year":"2025","journal-title":"JAMA Surg"},{"key":"2026070714021384400_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae134","article-title":"Tracheal reconstruction using stented aortic matrices in advanced thyroid cancer","volume":"111","author":"Kuczma","year":"2024","journal-title":"Br J Surg"},{"key":"2026070714021384400_bib4","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1111\/ajt.17137","article-title":"Airway replacement using stented aortic matrices: long-term follow-up and results of the TRITON-01 study in 35 adult patients","volume":"22","author":"Martinod","year":"2022","journal-title":"Am J Transplant"},{"key":"2026070714021384400_bib5","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1001\/jama.2018.4653","article-title":"Feasibility of bioengineered tracheal and bronchial reconstruction using stented aortic matrices","volume":"319","author":"Martinod","year":"2018","journal-title":"JAMA"},{"key":"2026070714021384400_bib6","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1200\/JCO.20.03093","article-title":"Open-label, single-arm, multicenter, phase II trial of lenvatinib for the treatment of patients with anaplastic thyroid cancer","volume":"39","author":"Wirth","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026070714021384400_bib7","doi-asserted-by":"crossref","first-page":"K33","DOI":"10.1530\/EJE-22-0366","article-title":"Detection of BRAFV600E by digital PCR on fine-needle aspirate enables rapid initiation of dabrafenib and trametinib in unresectable anaplastic thyroid carcinoma","volume":"187","author":"Buffet","year":"2022","journal-title":"Eur J Endocrinol"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/14\/6\/ETJ-25-0337.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/14\/6\/ETJ-25-0337.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0337\/506997\/etj-25-0337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0337\/506997\/etj-25-0337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:02:20Z","timestamp":1783447340000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/14\/6\/ETJ250337\/75681\/Rationale-for-using-lenvatinib-as-an-urgent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0337","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"ETJ250337"}}